New news from basic medicine

1

Up-regulation ratio

Recently, a circulating document shows that Jiangxi Province has recently adjusted the requirements for the proportion of essential medicines in public medical institutions.

According to the document, according to the "Opinions of the General Office of the State Council on Improving the National Essential Drug System" (Guobanfa [2018] No.

1.

2.

3.

4.

In addition to the proportion of use, other specific management requirements for the provision and use of essential medicines continue to implement the "Management Measures for the Provision and Use of Essential Medicines in Medical Institutions of Jiangxi Province" (Ganwei Yaoshifa [2019] No.

The above regulations will come into effect on April 1, 2021.

2

The proportion of base drugs is gradually increasing

Compared with the essential medicine provision documents released in 2019, the proportion of primary medical institutions in Jiangxi Province has risen from 50% to 70%, the proportion of secondary hospitals has risen from 40% to 50%, and the tertiary hospitals have also increased by 7%.

According to data released by Jiangxi Province on March 17, in 2020, the province's purchase of essential drugs will account for 39.

The report shows that the steady increase in the use rate of essential medicines in Jiangxi Province is mainly due to the establishment of a "triad" assessment system, which focuses on monitoring and assessment, reporting the use of medicines every quarter, doing case analysis, and following supervision letters , Refers to the direction of rectification; using the assessment of funds as the baton, the basic drug system subsidy funds have been assessed and settled for many consecutive years; using the medical reform assessment as a weather vane, the province's medical reform assessment has included the use of essential drugs for two consecutive years, accounting for 7 %, to promote the implementation of the basic drug system by governments and medical institutions at all levels.

In fact, it is not Jiangxi Province.

In 2020, the Shandong Provincial Health Commission issued a notice that starting from May 2020, medical institutions at all levels are required to fully equip and give priority to the use of essential medicines, and form a 1+x medication mode dominated by essential medicines.

On the basis of the "Shandong Provincial Health Commission and Shandong Provincial Market Supervision Administration's Notice on Further Strengthening the Management of the Provision and Use of Essential Medicines in Public Medical Institutions", the proportion of essential medicines used will be further increased and the province's primary medical and health care will be promoted.

In November 2019, the Jiangsu Provincial Health Commission issued a notice to issue a comprehensive pilot program for the implementation of the national essential drug system in the province, and select six regions to carry out the provincial comprehensive pilot program for the implementation of the national essential drug system.

The number of products that require the use of essential drugs and the amount of money are increased by 5 per year on the basis of the "Notice of the Provincial Health Commission on Further Strengthening the Management of the Provision and Use of Essential Drugs in Medical and Health Institutions" (Su Wei Yao Zheng [2019] No.

3

Essential medicine catalog, coming soon?

On March 1, the 2021 national drug administration video and telephone conference was held.
The first key task was to fully promote the implementation of the essential drug system: prioritize the allocation and use of essential drugs, strengthen the evaluation and publicity of the essential drug system, and optimize and adjust the national basic drug system.
Drug list.

In November 2020, relevant departments have held a symposium on the revision of the essential medicines catalogue management measures, and invited 16 provinces (municipalities) including Hebei, Shanxi, Inner Mongolia, Jilin, Shanghai, Jiangsu, Shandong, Henan and other 16 provinces (municipalities) of the health Leading Office for Political Work), commissioned by the Drug Management Center and relevant experts to promote the revision of the Essential Drugs List Management Measures, which means that the Essential Drug List Management Measures have been officially launched.

In accordance with the requirements of the time schedule, the list will be adjusted according to the contents of the method when the basic medicine management method is revised; coupled with the three-year adjustment cycle arrangement, it is expected that the adjustment of the basic medicine list will be the focus of the work of relevant departments this year.

Judging from the latest expansion of the basic medicine catalog in 2018, a total of 120 new pharmaceutical varieties and western medicine varieties were added.
In 2017, the total sales scale of the sample hospitals was 35.
569 billion yuan, which is estimated at a ratio of 1:4, corresponding to the actual market space close to 150 billion yuan.

Some professionals in the industry believe that: medical insurance products, classic drugs with sufficient international evidence-based evidence; in order to cover more diseases and meet the needs of all medical institutions, some new generic drugs or the direction of future basic drug adjustments should be expanded.

But in general, a more obvious trend in the basic drug catalog is that it is no longer limited to general drugs, and more high-value patent drugs such as anti-tumor targeted drugs are included.
From the perspective of ensuring supply and guiding clinical rational use of drugs, the basic drug catalog will become more and more guiding, which will promote the increase of the included varieties to a certain extent.